OTX008 : Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells

Mubritinib :Effectiveness of EGFR/HER2-targeted drugs is influenced by the downstream interaction shifts of PTPIP51 in HER2-amplified breast cancer cells

EPZ005687 : Targeting EZH2 in cancer

Elexacaftor :Therapie der Mukoviszidose – neue Medikamente geben Hoffnung

Pyrvinium: Inhibitory effect of the anthelmintic drug pyrvinium pamoate on T315I BCR‑ABL‑positive CML cells